Infectious Diseases and HIV Conference

Neurological infections are an area of utmost concern and significance in the scenario of infectious diseases, such as a major impetus to morbidity and mortality in patients.

This session is directed towards an overview of neurological infections in the light of their pathophysiology, clinical manifestations, diagnostic challenges, and the latest advancement in treatment. Different pathogens such as bacteria, viruses, fungi, and parasites that cause central nervous system infections have been discussed.

Neurological infections such as meningitis, encephalitis, brain abscesses, and neurocysticercosis have been explained with all the varied clinical features and issues associated with a diagnosis.

Participants will learn the epidemiology of these infections and what specific pathogens are responsible, such as Streptococcus pneumonia, Neisseria meningitidis, herpes simplex virus, and Toxoplasma Gondi. Accurate diagnosis of neurological infections might be very crucial for effective treatment.

Techniques in diagnosis include lumbar puncture for the analysis of cerebrospinal fluid, advanced imaging modalities like MRI and CT scans, and serological and molecular tests in the identification of infectious agents. In this session, these would be discussed to be known as a basis for timely intervention.

Generally, treatment strategies for neurological infections are multifaceted and complex. The participants will discuss the current best practices on how to handle conditions like bacterial meningitis and viral encephalitis management, using different antibiotics, antivirals, and supportive care.

Besides, the participants would discuss the trend of antimicrobial resistance and its impact on the treatment's efficacy. The presentations will also include emerging therapies as well as new approaches that focus on targeted therapies to certain types of pathogens, adjunctive therapies, and vaccinations in terms of preventing neurological infections in specific.

In addition to this, treatment sessions should base their treatment but significantly dwell on public health initiatives that prevent infectious agents from spreading neurological diseases.

That is, by fostering collaboration between the providers of healthcare, researchers, and public health officials, we can enhance our response to neurological infections, and in so doing, improve outcomes for affected patients.

We would have this session with the leading experts so that they share their insights and experience in paving a pathway for advancement in the management of neurological infections.